Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CD44抗体
Document Type and Number:
Japanese Patent JP2010512790
Kind Code:
A
Abstract:
The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to CD44, and that function to inhibit CD44. The invention also relates to heavy and light chain immunoglobulins derived from human CD44 antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human CD44 antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions or medicaments for treatment.

More Like This:
JP2017525370Tumor necrosis factor superfamily and TNF-like ligand mutein as well as tumor necrosis factor super-file method of preparing and using Millie and TNF-like ligand muteins
WO/2001/092502CUTINASE VARIANTS
JP4996934Recombinant lysozyme manufacturing method
Inventors:
Shoe shoe
Verge Bedian
Erica Meadow
Hai Chun Huang
Run Yang
Christopher toy
Mohan Srinivasan
Advise Vie Budkar
Application Number:
JP2009542902A
Publication Date:
April 30, 2010
Filing Date:
December 20, 2007
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Medarex, Inc.
Pfizer Inc.
International Classes:
C12N15/09; A61K39/395; A61P1/04; A61P9/10; A61P11/06; A61P17/06; A61P19/02; A61P25/00; A61P29/00; A61P35/00; A61P37/06; A61P43/00; C07K16/28; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/02; C12P21/08
Attorney, Agent or Firm:
Junji Yuda
Shoji Miwa
Noriyuki Takebayashi
Chika Takagi



 
Previous Patent: 信頼性の高い有害生物検出

Next Patent: ＣＤ２００Ｒに対する抗体